Abstract
Thyroid carcinoma arising from normal follicular cells is generally slow-growing with an excellent prognosis if competently resected. However, once the tumor dedifferentiates and becomes undifferentiated (anaplastic) carcinoma, it becomes one of the most aggressive malignancies. Such a polarized characteristic is quite unique yet typical of thyroid carcinoma. To date, many researchers have studied differences in the characteristics of thyroid carcinoma before and after dedifferentiation. In this review, the difference in cell proliferating activity and the expression of cell cycle modulators is addressed. Cell proliferating activity of undifferentiated carcinoma is definitely higher than that of differentiated carcinoma. However, expression of cell cycle modulators in thyroid carcinoma is often unique and even discrepant. Some negative modulators are diffusely expressed and reduced expression of some positive modulators can be observed in undifferentiated carcinoma. We described these interesting findings in thyroid carcinoma in this review.
Keywords: thyroid cancer, cell cycle, cell proliferation
Current Cancer Therapy Reviews
Title: Expression of Cell Cycle Regulators in Thyroid Neoplasms Originating from Follicular Cells
Volume: 1 Issue: 2
Author(s): Yasuhiro Ito
Affiliation:
Keywords: thyroid cancer, cell cycle, cell proliferation
Abstract: Thyroid carcinoma arising from normal follicular cells is generally slow-growing with an excellent prognosis if competently resected. However, once the tumor dedifferentiates and becomes undifferentiated (anaplastic) carcinoma, it becomes one of the most aggressive malignancies. Such a polarized characteristic is quite unique yet typical of thyroid carcinoma. To date, many researchers have studied differences in the characteristics of thyroid carcinoma before and after dedifferentiation. In this review, the difference in cell proliferating activity and the expression of cell cycle modulators is addressed. Cell proliferating activity of undifferentiated carcinoma is definitely higher than that of differentiated carcinoma. However, expression of cell cycle modulators in thyroid carcinoma is often unique and even discrepant. Some negative modulators are diffusely expressed and reduced expression of some positive modulators can be observed in undifferentiated carcinoma. We described these interesting findings in thyroid carcinoma in this review.
Export Options
About this article
Cite this article as:
Ito Yasuhiro, Expression of Cell Cycle Regulators in Thyroid Neoplasms Originating from Follicular Cells, Current Cancer Therapy Reviews 2005; 1 (2) . https://dx.doi.org/10.2174/1573394054021736
DOI https://dx.doi.org/10.2174/1573394054021736 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phytosterols: Perspectives in Human Nutrition and Clinical Therapy
Current Medicinal Chemistry Mechanism of Action and Therapeutic Potential of Novel Adamantyl Retinoid-Related Molecules
Current Cancer Therapy Reviews From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Current Cancer Drug Targets Sonoelastography for Pelvic Metastatic Malignant Pheochromocytoma: A Case Report
Current Medical Imaging Stem Cell Transplantation in Pediatric Leukemia and Myelodysplasia: State of the Art and Current Challenges
Current Stem Cell Research & Therapy Synthesis and Cytotoxic Activity of New β-Carboline Derivatives
Mini-Reviews in Medicinal Chemistry Pulmonary Hypertension: Current Therapy and Future Prospects
Cardiovascular & Hematological Agents in Medicinal Chemistry Radionuclide Liver Cancer Therapies: From Concept to Current Clinical Status
Anti-Cancer Agents in Medicinal Chemistry Long Range Regulatory Sequences Delimited by Progressive Deletions of a Mouse Nkx2-5-GFP-BAC Clone: A New Approach to Identify Distal Gene Regulators in Evolutionarily Conserved Non-Coding Sequences
Current Genomics Biology of PPARγ in Cancer: A Critical Review on Existing Lacunae
Current Molecular Medicine Post-translational and Post-transcriptional Modifications of Pregnane X Receptor (PXR) in Regulation of the Cytochrome P450 Superfamily
Current Drug Metabolism Ghrelin: New Insight to Mechanisms and Treatment of Postoperative Gastric Ileus
Current Pharmaceutical Design Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
Current Medicinal Chemistry Relationship Between Vitamin D Deficiency and Chronic Low Back Pain in Postmenopausal Women
Current Rheumatology Reviews Role of Nanoparticles in Drug Delivery and Regenerative Therapy for Bone Diseases
Current Drug Delivery Prognostic and Predictive Biomarkers in Cancer
Current Cancer Drug Targets CircRNAs and Axes Involved in Thyroid Cancer based on PTC: A Biomarker for Prognosis, Diagnosis and Treatment
Current Signal Transduction Therapy Cancer Metastasis: Characterization and Identification of the Behavior of Metastatic Tumor Cells and the Cell Adhesion Molecules, including Carbohydrates
Current Drug Targets - Cardiovascular & Hematological Disorders Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor Modulators
Current Medicinal Chemistry Amyloidogenicity of p53: A Hidden Link Between Protein Misfolding and Cancer
Current Protein & Peptide Science